Study links liver-disease subtypes with different responses over 48 weeks
Among 618 people with MASLD, metabolic classification systems were associated with differences in liver-fat, enzyme and stiffness responses during lifestyle management.
Moderate evidenceHuman studySome caution advised
Medical disclaimer: This article summarizes research findings and is for informational purposes only. It is not medical advice.
Editorial illustration — not from the study.
The researchers compared three ways of grouping people with MASLD: metabolic clusters, liver and cardiometabolic traits, and biochemical injury patterns. They assessed changes using MRI-based liver-fat measurements, ALT levels and liver-stiffness measurements rather than repeated liver biopsies.
Metabolic clusters were more stable over time than the other two classification systems. Several subgroups also had different response patterns, including lower liver-fat response in the high-lipoprotein(a) group, lower ALT response in the age-related group and a stronger liver-stiffness response in the mild-obesity/dyslipidemia group. These findings describe associations within this cohort and do not establish that a particular classification or treatment approach improves outcomes.
What was studied
Researchers conducted a prospective observational cohort study involving 618 people with MASLD who underwent 48 weeks of guideline-based lifestyle management. They compared three phenotyping frameworks: five metabolic clusters, including mild obesity/dyslipidemia-associated, age-related, severe insulin-resistance-associated, high-lipoprotein(a)-associated and severe mixed-hyperlipidemia-associated MASLD; hepatic and cardiometabolic traits; and biochemical patterns classified as hepatocellular, mixed or cholestatic. The main response measures were at least a 30% relative reduction in MRI-derived liver fat, an ALT decrease of at least 17 IU/L and at least a one-stage improvement in liver stiffness-defined fibrosis stage.
What researchers observed
Metabolic clusters had greater temporal stability than the hepatic and cardiometabolic trait system and the biochemical pattern system: 62.8%, 56.6% and 53.4%, respectively. Compared with other clusters, the high-lipoprotein(a)-associated group had lower odds of meeting the liver-fat response threshold, with an odds ratio of 0.35 and a 95% confidence interval of 0.15 to 0.79. The age-related group had lower odds of meeting the ALT response threshold, with an odds ratio of 0.33 and a 95% confidence interval of 0.18 to 0.62. The mild-obesity/dyslipidemia-associated group had a stronger liver-stiffness response than the other metabolic clusters. The liver-specific trait group had better responses across all three measures than the control trait group. Biochemical patterns mainly distinguished ALT responses, with the hepatocellular pattern showing a greater response than the mixed and cholestatic patterns. Because this was an observational study, these results indicate associations and do not show that the subtypes caused the differences.
Who this is relevant to
The findings may be relevant to people with MASLD who are similar to the 618 participants studied and who underwent comparable 48-week guideline-based lifestyle management. They should not automatically be applied to people with different liver conditions, different clinical characteristics or different management circumstances. The study does not establish that these classifications predict individual outcomes or that changing management according to a subtype would improve health.
Why it matters
MASLD is a varied human disease, and the study suggests that different ways of grouping patients may identify different response patterns during a 48-week period. This may help researchers evaluate whether classification systems can support more individualized research and monitoring. However, the measured outcomes were noninvasive indicators of liver fat, ALT and liver stiffness, so the results do not by themselves establish changes in long-term health, cirrhosis risk or survival.
Limitations & evidence assessment
The study was observational rather than randomized, so differences between groups or other factors could account for some of the observed associations. Follow-up lasted 48 weeks, which limits what can be concluded about longer-term outcomes. The study used MRI-based liver fat, ALT and liver-stiffness measurements instead of serial liver biopsies, and the excerpts do not provide enough information about recruitment, adherence, missing data, possible confounding or how representative the participants were. The abstract also does not describe a separate randomized control group.
Why this evidence level: This was a prospective observational cohort study of 618 people with MASLD, which provides more information than a small or cross-sectional study. However, it was not described as randomized, so the findings show associations with responses rather than proving that the subtypes caused different outcomes.
Evidence levels are editorial estimates derived from study metadata — they are not clinical appraisals.
Researchers combined genetic data from more than 1 million human participants to study factors associated with endometriosis. They identified 58 genomic regions, including 27 not previously reported, and used additional molecular analyses to implicate 314 genes. These findings point to possible biological pathways for further research, but they do not establish causes or demonstrate that any treatment will work.
Researchers systematically reviewed laboratory studies of how temperature affects the time it takes arboviruses to become transmissible inside mosquitoes. Across 53 studies covering 17 viruses, higher temperatures were generally linked with greater transmission efficiency and a shorter time to infectiousness for Zika and West Nile viruses, while results for several other viruses were unclear.
This systematic review and meta-analysis examined whether ultra-low-dose computed tomography (CT) can detect pulmonary, or lung, nodules while using less radiation than standard-dose CT. Across 42 studies involving 15,792 patients, pooled sensitivity for nodule detection was 91.9%, but results varied greatly between studies. The review also found that ultra-low-dose CT used an average effective dose of 0.22 millisieverts (mSv), while detection was less reliable for some small or hazy nodules and in patients with a high body mass index.